Noninfectious Uveitis Risk After COVID-19 Vaccination: A Nationwide Retrospective Cohort Study

Since the onset of the global COVID-19 pandemic, a rapid surge in the number of cases during the initial outbreak precipitated the prompt development and distribution of vaccines for the general population. As of April 2023, 69.8% of the world's population has received ≥1 dose of a COVID-19 vaccine,1 and in the Republic of Korea, 87.6% of the population (approximately 44.8 million individuals) has received ≥1 dose.2

Source: American Journal of Ophthalmology - September 19, 2023 Category: Opthalmology Authors: Myung Soo Chang, Hae Rang Kim, Sunyeup Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Seung Won Lee, Yong Joon Kim Tags: Original articles Source Type: research